Novartis’ Newly Licensed Antidepressant Hits Snag In EU Under Separate Sponsor

EMEA’s review committee recommends against authorization of agomelatine, but sides with Gardasil and Champix/Chantix.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet